Viewing Study NCT00044668


Ignite Creation Date: 2025-12-24 @ 5:57 PM
Ignite Modification Date: 2026-01-02 @ 7:06 AM
Study NCT ID: NCT00044668
Status: COMPLETED
Last Update Posted: 2015-02-20
First Post: 2002-09-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None exenatide View
None exendin-4 View
None diabetes View
None Amylin View
None Lilly View